These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34746493)

  • 1. Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids.
    Dalal S; Chitneni A; Berger AA; Orhurhu V; Dar B; Kramer B; Nguyen A; Pruit J; Halsted C; Kaye AD; Hasoon J
    Health Psychol Res; 2021; 9(1):27241. PubMed ID: 34746493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain.
    Pergolizzi JV; Raffa RB
    J Pain Res; 2019; 12():3299-3317. PubMed ID: 31997882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion.
    Webster L; Gudin J; Raffa RB; Kuchera J; Rauck R; Fudin J; Adler J; Mallick-Searle T
    Pain Med; 2020 Apr; 21(4):714-723. PubMed ID: 31917418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utilization of buprenorphine in chronic pain.
    Urits I; Pham C; Swanson D; Berardino K; Bandi P; Amgalan A; Kaye RJ; Jung JW; Kaye AD; Paladini A; Varrassi G; Kaye AM; Manchikanti L; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):355-368. PubMed ID: 33004153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.
    Gudin J; Fudin J
    Pain Ther; 2020 Jun; 9(1):41-54. PubMed ID: 31994020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-Risk Analysis of Buprenorphine for Pain Management.
    Hale M; Garofoli M; Raffa RB
    J Pain Res; 2021; 14():1359-1369. PubMed ID: 34079354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine buccal film for chronic pain management.
    Hale M; Gimbel J; Rauck R
    Pain Manag; 2020 Jul; 10(4):213-223. PubMed ID: 32394800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Access to On-Label Formulations of Buprenorphine for Chronic Pain as Compared with Conventional Opioids.
    Fishman MA; Scherer A; Topfer J; Kim PSH
    Pain Med; 2020 May; 21(5):1005-1009. PubMed ID: 31697314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal buprenorphine for moderate chronic noncancer pain syndromes.
    Pergolizzi JV; Coluzzi F; Taylor R
    Expert Rev Neurother; 2018 May; 18(5):359-369. PubMed ID: 29667437
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical opioids and their effect on respiratory drive.
    Webster L; Rauck RL
    J Opioid Manag; 2021; 17(7):109-118. PubMed ID: 34520032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine.
    Daitch J; Frey ME; Silver D; Mitnick C; Daitch D; Pergolizzi J
    Pain Physician; 2012 Jul; 15(3 Suppl):ES59-66. PubMed ID: 22786462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of Schedule II Opioids to Buprenorphine Buccal Film: A Retrospective Analysis.
    Zimmerman A; Bikdash R; Rauck R
    Pain Med; 2021 May; 22(5):1109-1115. PubMed ID: 32914182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique role of transdermal buprenorphine in the global chronic pain epidemic.
    Pergolizzi JV; Scholten W; Smith KJ; Leighton-Scott J; Willis JC; Henningfield JE
    Acta Anaesthesiol Taiwan; 2015 Jun; 53(2):71-6. PubMed ID: 26205326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The switch from buprenorphine to tapentadol: is it worth?
    Miclescu A
    Rom J Anaesth Intensive Care; 2016 Oct; 23(2):133-139. PubMed ID: 28913486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine.
    Mendelson J; Flower K; Pletcher MJ; Galloway GP
    Exp Clin Psychopharmacol; 2008 Oct; 16(5):435-41. PubMed ID: 18837640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine: revisiting the efficacy of transdermal delivery system.
    Kitzmiller JP; Barnett CJ; Steiner NS; Stoicea N; Kamar N; Luzum JA; Mikulik E; Bergese SD
    Ther Deliv; 2015; 6(4):419-22. PubMed ID: 25996041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine-Clinically useful but often misunderstood.
    Butler S
    Scand J Pain; 2013 Jul; 4(3):148-152. PubMed ID: 29913911
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.